Literature DB >> 24123628

Measuring overfitting in nonlinear models: a new method and an application to health expenditures.

Marcel Bilger1, Willard G Manning.   

Abstract

When fitting an econometric model, it is well known that we pick up part of the idiosyncratic characteristics of the data along with the systematic relationship between dependent and explanatory variables. This phenomenon is known as overfitting and generally occurs when a model is excessively complex relative to the amount of data available. Overfitting is a major threat to regression analysis in terms of both inference and prediction. We start by showing that the Copas measure becomes confounded by shrinkage or expansion arising from in-sample bias when applied to the untransformed scale of nonlinear models, which is typically the scale of interest when assessing behaviors or analyzing policies. We then propose a new measure of overfitting that is both expressed on the scale of interest and immune to this problem. We also show how to measure the respective contributions of in-sample bias and overfitting to the overall predictive bias when applying an estimated model to new data. We finally illustrate the properties of our new measure through both a simulation study and a real-data illustration based on inpatient healthcare expenditure data, which shows that the distinctions can be important.
Copyright © 2013 John Wiley & Sons, Ltd.

Keywords:  Copas test; forecasting; health expenditure; overfitting; shrinkage

Mesh:

Year:  2013        PMID: 24123628     DOI: 10.1002/hec.3003

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  8 in total

1.  Age, choline-to-N-acetyl aspartate, and lipids-lactate-to-creatine ratios assemble a significant Cox's proportional-hazards regression model for survival prediction in patients with high-grade gliomas.

Authors:  Zhenyin Liu; Jing Zhang
Journal:  Br J Radiol       Date:  2017-06-20       Impact factor: 3.039

2.  Health-related quality of life and health utilities in insulin-treated type 2 diabetes: the impact of related comorbidities/complications.

Authors:  John Yfantopoulos; Athanasios Chantzaras
Journal:  Eur J Health Econ       Date:  2020-03-03

3.  Treatment recommendations for schizophrenia, major depression and alcohol dependence and stigmatizing attitudes of the public: results from a German population survey.

Authors:  Sven Speerforck; Georg Schomerus; Herbert Matschinger; Matthias C Angermeyer
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-12-28       Impact factor: 5.270

4.  Reconsidering lactate as a sepsis risk biomarker.

Authors:  John L Moran; John Santamaria
Journal:  PLoS One       Date:  2017-10-03       Impact factor: 3.240

5.  Non-invasive Quantification of Fat Deposits in Skeletal Muscle Predicts Cardiovascular Outcome in Kidney Failure.

Authors:  Mehdi Keddar; Thibaut Muylle; Emmanuelle Carrie; Pierre Trefois; Maxime Nachit; Ralph Crott; Claudine Christiaens; Bert Bammens; Michel Jadoul; Eric Goffin; Johann Morelle
Journal:  Front Physiol       Date:  2020-02-25       Impact factor: 4.566

6.  Culture and COVID-19-related mortality: a cross-sectional study of 50 countries.

Authors:  Arnold Käffer; Jörg Mahlich
Journal:  J Public Health Policy       Date:  2022-08-22       Impact factor: 3.526

7.  Modelling hospital outcome: problems with endogeneity.

Authors:  John L Moran; John D Santamaria; Graeme J Duke
Journal:  BMC Med Res Methodol       Date:  2021-06-21       Impact factor: 4.615

8.  Feature Selection for Health Care Costs Prediction Using Weighted Evidential Regression.

Authors:  Belisario Panay; Nelson Baloian; José A Pino; Sergio Peñafiel; Horacio Sanson; Nicolas Bersano
Journal:  Sensors (Basel)       Date:  2020-08-06       Impact factor: 3.576

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.